This trial studies how well wearable exercise tracker watch works in monitoring physical activity in participants during cancer rehabilitation. A wearable exercise tracker watch may be helpful to monitor physical activity.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT03042884.
PRIMARY OBJECTIVES:
I. To obtain preliminary exploratory data on cancer patients’ perception of usefulness of a wearable exercise tracker (Fitbit Charge HR) to monitor physical activity in both inpatient and outpatient settings, separately.
SECONDARY OBJECTIVES:
I. To identify subgroups of patients (age, gender, race, socioeconomic status, symptom burden [as measured by the Edmonton Symptom Assessment Scale (ESAS)], functional status [as measured by Functional Independence Measure (FIM) scores], activity level and cancer type) who express a higher level (if patients answered partially agree or strongly agree in the self-reported de-identified questionnaire) of usefulness of a wearable exercise tracker.
OUTLINE: Participants are assigned to 1 of 2 arms.
ARM I: Outpatient participants wear exercise tracker watch over 24 hours per day for 14 days.
ARM II: Inpatient participants wear exercise tracker watch over 24 hours per day until within 24 hours before discharge.
Trial PhaseNo phase specified
Trial Typesupportive care
Lead OrganizationUT MD Anderson Cancer Center
Principal InvestigatorAmy Ng
